Merck - Back of the Envelope Analysis
I played around with Merck's financials this morning. It appears that MRK will be able to keep paying the dividend despite major blockbuster expirations (Zocor and Fosomax) without dipping substantially into its $13 billion war chest. Here is my back of the envelope analysis (excel spreadsheet).
Vitaliy N. Katsenelson, CFA
This article is written for educational purposes only. It is not intended as a recommendation to buy or sell securities. Author and/or his employer may have a position in the securities discussed in this article. Security positions may change at any time.
posted by Vitaliy N. Katsenelson, CFA at 9/07/2005 02:56:00 PM
2 Comments:
Interesting blog. While I focus mostly on the technology sector, a lot of your posts are very insightful (esp. the earnings game). Best of luck with your blog.
-Craig
http://techstockblog.blogspot.com/
do you have a rss feed? I was going to add your blog to my newsreader, but did not notice any type of sydication/rss feeds?
Post a Comment
<< Home